Jiangsu Nhwa Pharmaceutical Co., Ltd
69 Minzhu South Road
Xuzhou
Jiangsu
221009
China
Tel: 86-516-87767115
Fax: 86-516-87767118
Website: http://www.nhwa-group.com/enhuaEnglish/
Email: nhwa@nhwa-group.com
About Jiangsu Nhwa Pharmaceutical Co., Ltd
Jiangsu Nhwa Pharmaceutical Corporation Ltd. is an integrated pharmaceutical corporation conducting technology, industry and distribution, and is the designated manufacturer of psychotropic drugs by National Ministry of Health. The company has been entitled as the National Hi-tech Enterprise and ranked among National Top 100 Pharmaceutical Enterprises, with Post-Doctoral Research Center, Post-Doctoral Innovation Center and Nationally Designated Technology Center, It's a public corporation listed on Shenzhen SME board, and the brandcertified corporation of International Environmental Standard System (ISO14000). Nhwa has been appraised as the famous brand in China.YEAR FOUNDED:
1978
6 articles about Jiangsu Nhwa Pharmaceutical Co., Ltd
-
Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in China
2/26/2024
Teva Pharmaceutical Investments Singapore Pte Ltd, a subsidiary of Teva Pharmaceutical Industries Ltd. and Jiangsu Nhwa Pharmaceutical Co., Ltd announced it formed a partnership for the marketing and distribution of Teva’s AUSTEDO for the treatment of neurodegenerative and movement disorders - chorea associated with Huntington’s disease and tardive dyskinesia in adults.
-
Scientists from Brigham and Women's Hospital are ready to start a clinical trial that will evaluate the use of an intranasal vaccine to prevent Alzheimer's disease.
-
I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical Announce Strategic Collaboration Agreement with Biodextris and a Boston-Based, Leading Academic Medical Center
4/8/2019
I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical announce on April 5th , 2019 that they have entered into collaborative research agreement with world-renowned scientists and clinicians at the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital and Biodextris, a Montreal-based biologics contract development and manufacturing organization, to jointly develop a novel immuno-stimulatory therapy for neurologic disorders by harnessing the natural power of the immune system.
-
Forbes came out with its ranking of the World’s Best Employers 2018, with a number of global biopharmaceutical companies ranked high on the list. Here’s the top 10 in that category.
-
Jiangsu Nhwa Pharmaceutical Acquires China Rights To Emergency Treatment For Blood Loss
1/27/2017
-
China's Jiangsu Nhwa Pharmaceutical To Start Trial Of In-Licensed Epilepsy Drug
4/15/2015